+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Benzodiazepine"

From
Pregabalin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pregabalin Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
From
Anticonvulsants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anticonvulsants Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Insomnia Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Insomnia Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Vertigo Drugs - Global Strategic Business Report - Product Thumbnail Image

Vertigo Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 267 Pages
  • Global
From
REM Sleep Behavior Disorders - Global Strategic Business Report - Product Thumbnail Image

REM Sleep Behavior Disorders - Global Strategic Business Report

  • Report
  • November 2026
  • 271 Pages
  • Global
From
From
Barbiturate Drugs - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 386 Pages
  • Global
From
Delirium - Global Strategic Business Report - Product Thumbnail Image

Delirium - Global Strategic Business Report

  • Report
  • November 2026
  • 281 Pages
  • Global
From
Cervical Dystonia Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Dystonia Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 276 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Thumbnail Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • November 2026
  • 180 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Sleeping Pills Market Report 2026 - Product Thumbnail Image

Sleeping Pills Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Tardive Dyskinesia Treatment Market Report 2026 - Product Thumbnail Image

Tardive Dyskinesia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Restless Leg Syndrome Market Report 2026 - Product Thumbnail Image

Restless Leg Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Dravet Syndrome Market Report 2026 - Product Thumbnail Image

Dravet Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Acute Agitation and Aggression Treatment Market Report 2026 - Product Thumbnail Image

Acute Agitation and Aggression Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lennox-Gastaut Syndrome Drug Market Report 2026 - Product Thumbnail Image

Lennox-Gastaut Syndrome Drug Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

Benzodiazepines are a class of psychoactive drugs used to treat mental disorders such as anxiety, insomnia, and seizures. They act on the central nervous system to produce a calming effect, and are often prescribed to treat symptoms of anxiety, panic, and insomnia. Benzodiazepines are also used to treat alcohol withdrawal, muscle spasms, and seizures. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse. Benzodiazepines are among the most commonly prescribed drugs in the world, and are widely used to treat a variety of mental health conditions. They are generally considered to be safe and effective when used as prescribed, but can be habit-forming and have the potential for abuse. Some companies in the benzodiazepine market include Pfizer, GlaxoSmithKline, Sanofi, and Mylan. Show Less Read more